About
Biologics
Areas of Focus
Categories
Biologics & BiopharmaceuticalChina
Clinical Trials (11)
View allTotal Trials
11
As Lead Sponsor
10
As Collaborator
1
Total Enrollment
592
By Phase
PHASE1: 7PHASE2: 1PHASE2/PHASE3: 1
By Status
COMPLETED: 6RECRUITING: 2NO_LONGER_AVAILABLE: 2UNKNOWN: 1
Clinical Trials Pipeline9 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT04947033Lead Sponsor
A Study Evaluating TJ210001 in the Treatment of Subjects With Advanced Solid Tumors
PHASE1Recruiting
25 participants
Started: Dec 31, 2023 · Completed: Dec 31, 2025
NCT07187141Collaborator
Nasal Protollin in Early Symptomatic Alzheimer's Disease
PHASE1Completed
16 participants
Started: Nov 18, 2021 · Completed: Feb 21, 2023
NCT05001347Lead Sponsor
A Clinical Study of TJ004309 With Atezolizumab (TECENTRIQ®) in Patients With Ovarian Cancer and Selected Solid Tumors
PHASE2Completed
25 participants
Started: Nov 2, 2021 · Completed: Feb 8, 2023
NCT04900818Lead Sponsor
Study of TJ033721 (givastomig) in Subjects with Advanced or Metastatic Solid Tumors
PHASE1Recruiting
168 participants
Started: Jun 29, 2021 · Completed: Dec 31, 2026
NCT04678921Lead Sponsor
Study of TJ210001 Administered in Subjects With Relapsed or Refractory Advanced Solid Tumors
PHASE1Completed
16 participants
Started: Dec 17, 2020 · Completed: Nov 21, 2022
Locations (1)
Headquarters
Shanghai, China
Map
Loading map...